Voice-Assisted Remote Symptom Monitoring for Gastrointestinal Cancer Surgery

This study is testing a Voice-Assisted Remote Symptom Monitoring System (VARSMS) to improve care after surgery for gastrointestinal (GI) cancer. If you are at least 18 years old, speak English, and have reliable Wi-Fi, you might be able to join. You would be scheduled for GI surgery for a tumor at a participating hospital. The VARSMS uses an Amazon Echo Dot to ask you questions about your symptoms. The study will measure your symptoms using a special questionnaire 40 days after surgery. This system is not used for diagnosis or treatment. The study is currently unclear about its recruitment status.

Study design
This is a randomized controlled trial comparing patients who use the VARSMS with a control group. It plans to enroll 281 participants.
What's involved
You would use an Alexa Skill on an Amazon Echo Dot device to answer questions about your symptoms.
Compensation
Not stated in the trial record.
Follow-up
Your symptoms will be measured 40 days after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06190730

REmote Symptom COllection to improVE postopeRative Care

Recruiting
NAAges 18+InterventionalSupportive care
Medstar Health Research Institute
~281 participants
Updated 2025-04-03 on ClinicalTrials.gov
What's tested:Voice-Assisted Remote Symptom Monitoring System (VARSMS)

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Custom questionnaire based on NCI PRO CTCAE (National Cancer Institute- Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events)
Measured over 40 days
Gastrointestinal Cancer
Gastrointestinal Tumor
Gastrointestinal Tumor Surgery
Gastrointestinal Surgery
2 sites across 2 states
Maryland1
Nebraska1

Opens a ready-to-send draft in your own email app — review before sending.

  • Custom questionnaire based on NCI PRO CTCAE (National Cancer Institute- Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events)40 days

    Daily symptom-based self-reported assessment on dyspnea, fever, melena, pain, wound healing, activities of daily living, sensorium, gastrointestinal motility, dysphagia, pitting edema, mood, and an option to mention symptoms not asked of. This is monitored by the research team, and any concerning finding, at the discretion of the site's physician, will be relayed to the subject's treating physician. Treating physician has final decision on whether to address referral by adjustment of management.